Eunpyeong St. Mary's Hospital Blood Hospital achieves 500 hematopoietic stem cell transplants...Strengthen the status of hospitals for treatment of severe blood diseases
May 30, 2025
The blood hospital at Eunpyeong St. Mary's Hospital of Catholic University achieved 500 hematopoietic stem cell transplants, further solidifying its status as a central hospital for treating severe blood diseases. In particular, it ranks sixth in the country in the number of hematopoietic stem cell transplants in 2024 following 2023, and has established itself as a key base hospital for the treatment of severe blood diseases in the northwest of the metropolitan area.
The achievement, six years after the first transplant in 2019, is the result of the expansion of high-level allografts, treatment outcomes for elderly and high-risk patients, and multidisciplinary customized treatment capabilities. In fact, out of a total of 500 transplants, 232 autologous transplants and 268 allogeneic transplants accounted for more than half of the total. Among them, 90 cases of non-blood-related transplants, 71 cases between brothers, 99 cases of semi-consistent transplants, and 8 cases of cord blood transplants were counted, demonstrating that various forms of high-level transplants were stably performed.
In particular, the ratio of semi-consistent transplants and non-blood-related transplants, which correspond to high-level treatment, was high, showing that effective treatment was stably provided even to patients with difficult donor conditions. In addition, cord blood transplantation, which requires infection prevention and precise patient management, is steadily performed and new treatment alternatives are provided to patients who are difficult to find donors.
Transplantation in elderly patients also continued to increase. From 2019 to the present, a total of 96 transplants have been made to patients over the age of 65, of which 15 have been made to patients over the age of 70. This is the result of showing the hospital's expertise and systematic patient management capabilities to successfully perform hematopoietic stem cell transplantation even for elderly and high-risk patients regardless of age and difficulty.
This high-level transplant capability was also demonstrated in the treatment of high-risk patients. The 500th transplant, a 67-year-old patient, was diagnosed with myelodysplastic syndrome (MDS) at the end of 2024 and received another hematopoietic stem cells on May 7, 2025, while using a wheelchair due to cerebral hemorrhage in 2020. The allogeneic transplant, which took place after the fourth round of chemotherapy, was successfully completed, and is currently recovering from stable implantation.
Professor Kim Byung-soo of Eunpyeong St. Mary's Hospital said, `This achievement of 500 cases is more than just a figure,' adding, `The results of the multidisciplinary cooperation system and the dedication of medical staff covering the entire process from thorough diagnosis before transplantation to recovery after transplantation.' In the future, regardless of the difficulty of treatment or the patient's age, we will do our best to provide the best treatment experience through precise and warm treatment that considers the quality of life of each patient" he said.
Meanwhile, Eunpyeong St. Mary's Hospital operated a blood hospital in earnest upon its opening in April 2019, and successfully performed the first hematopoietic stem cell transplant in July of the same year. Since then, it has opened the multiple myeloma center for the first time in Korea, and has established a patient-specific treatment system by operating a cooperative team consisting of various specialized departments such as diagnostic test medicine, radiology, nuclear medicine, radiation oncology, orthopedic surgery, and infectious medicine, focusing on hematology. The treatment infrastructure is also continuously expanding, such as strengthening infection control and side effect prevention systems, and expanding the sterile hospital beds dedicated to transplantation to 14 beds.
In addition, Eunpyeong St. Mary's Hospital Blood Hospital is a key institution in the 'Catholic Blood Hospital' network with the world's best blood disease treatment capabilities along with Seoul St. Mary's Hospital and Yeouido St. Mary's Hospital, providing consistent and high-level treatment to patients through standardization of treatment, ward operation, and nursing services. In particular, based on close connection with Seoul St. Mary's Hospital, it is implementing a one-stop multidisciplinary treatment that is quick and precise from diagnosis to treatment for major blood cancers such as multiple myeloma, malignant lymphoma, and leukemia, helping patients with severe blood diseases to be treated more effectively.
The achievement, six years after the first transplant in 2019, is the result of the expansion of high-level allografts, treatment outcomes for elderly and high-risk patients, and multidisciplinary customized treatment capabilities. In fact, out of a total of 500 transplants, 232 autologous transplants and 268 allogeneic transplants accounted for more than half of the total. Among them, 90 cases of non-blood-related transplants, 71 cases between brothers, 99 cases of semi-consistent transplants, and 8 cases of cord blood transplants were counted, demonstrating that various forms of high-level transplants were stably performed.
In particular, the ratio of semi-consistent transplants and non-blood-related transplants, which correspond to high-level treatment, was high, showing that effective treatment was stably provided even to patients with difficult donor conditions. In addition, cord blood transplantation, which requires infection prevention and precise patient management, is steadily performed and new treatment alternatives are provided to patients who are difficult to find donors.
Transplantation in elderly patients also continued to increase. From 2019 to the present, a total of 96 transplants have been made to patients over the age of 65, of which 15 have been made to patients over the age of 70. This is the result of showing the hospital's expertise and systematic patient management capabilities to successfully perform hematopoietic stem cell transplantation even for elderly and high-risk patients regardless of age and difficulty.
This high-level transplant capability was also demonstrated in the treatment of high-risk patients. The 500th transplant, a 67-year-old patient, was diagnosed with myelodysplastic syndrome (MDS) at the end of 2024 and received another hematopoietic stem cells on May 7, 2025, while using a wheelchair due to cerebral hemorrhage in 2020. The allogeneic transplant, which took place after the fourth round of chemotherapy, was successfully completed, and is currently recovering from stable implantation.
Professor Kim Byung-soo of Eunpyeong St. Mary's Hospital said, `This achievement of 500 cases is more than just a figure,' adding, `The results of the multidisciplinary cooperation system and the dedication of medical staff covering the entire process from thorough diagnosis before transplantation to recovery after transplantation.' In the future, regardless of the difficulty of treatment or the patient's age, we will do our best to provide the best treatment experience through precise and warm treatment that considers the quality of life of each patient" he said.
Meanwhile, Eunpyeong St. Mary's Hospital operated a blood hospital in earnest upon its opening in April 2019, and successfully performed the first hematopoietic stem cell transplant in July of the same year. Since then, it has opened the multiple myeloma center for the first time in Korea, and has established a patient-specific treatment system by operating a cooperative team consisting of various specialized departments such as diagnostic test medicine, radiology, nuclear medicine, radiation oncology, orthopedic surgery, and infectious medicine, focusing on hematology. The treatment infrastructure is also continuously expanding, such as strengthening infection control and side effect prevention systems, and expanding the sterile hospital beds dedicated to transplantation to 14 beds.
In addition, Eunpyeong St. Mary's Hospital Blood Hospital is a key institution in the 'Catholic Blood Hospital' network with the world's best blood disease treatment capabilities along with Seoul St. Mary's Hospital and Yeouido St. Mary's Hospital, providing consistent and high-level treatment to patients through standardization of treatment, ward operation, and nursing services. In particular, based on close connection with Seoul St. Mary's Hospital, it is implementing a one-stop multidisciplinary treatment that is quick and precise from diagnosis to treatment for major blood cancers such as multiple myeloma, malignant lymphoma, and leukemia, helping patients with severe blood diseases to be treated more effectively.
|
This article was translated by Naver AI translator.
